KITE-585

· Kite, A Gilead Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KITE-585, covering 2020-05-26 to 2020-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma [Phase 1]

See pricing